Related Experiment Video
Updated: Jan 20, 2026
Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
Published on: May 31, 2020
Zika virus and the never-ending story of emerging pathogens and transfusion medicine
Giuseppe Marano1, Simonetta Pupella1, Stefania Vaglio1,2
1Italian National Blood Centre, National Institute of Health, Rome, Italy.
Abstract:
In the last few years, the transfusion medicine community has been paying special attention to emerging vector-borne diseases transmitted by arboviruses. Zika virus is the latest of these pathogens and is responsible for major outbreaks in Africa, Asia and, more recently, in previously infection-naïve territories of the Pacific area. Many issues regarding this emerging pathogen remain unclear and require further investigation. National health authorities have adopted different prevention strategies. The aim of this review article is to discuss the currently available, though limited, information and the potential impact of this virus on transfusion medicine.
Insights
Zika virus, an emerging arbovirus, poses risks to transfusion medicine. This review examines current knowledge and potential impacts on blood safety and transfusion practices.
Area of Science:
- Transfusion Medicine
- Virology
- Public Health
Background:
- Emerging vector-borne diseases, particularly arboviruses, are a growing concern in transfusion medicine.
- Zika virus (ZIKV) has caused significant outbreaks globally, including in previously uninfected regions.
- Limited understanding of ZIKV transmission and its implications for blood supply necessitates review.
Purpose of the Study:
- To review the current, albeit limited, information on Zika virus.
- To discuss the potential impact of Zika virus on transfusion medicine practices and blood safety.
- To highlight areas requiring further investigation regarding ZIKV in the context of blood transfusion.
Main Methods:
- Literature review of scientific publications and health authority reports on Zika virus.
- Analysis of existing data on arbovirus transmission relevant to transfusion medicine.
- Synthesis of information regarding ZIKV epidemiology, diagnostics, and prevention strategies.
Main Results:
- Zika virus is a significant emerging arbovirus with potential for transfusion-transmitted infection.
- Current data on ZIKV's impact on transfusion medicine remains limited.
- Various national health authorities have implemented diverse prevention strategies.
Conclusions:
- Further research is crucial to fully understand and mitigate the risks of Zika virus in transfusion medicine.
- Effective strategies are needed to ensure blood safety in the face of emerging arboviruses like ZIKV.
- Continuous monitoring and adaptation of transfusion practices are essential for public health protection.
Related Concept Videos
10:35Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
07:53Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
10:01Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
11:37Zika Virus Specific Diagnostic Epitope Discovery
07:35Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
02:21Zika Virus Infection of Fetal Neural Stem Cells